Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.70 +0.01 (+1.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Change in Account Payables (2025 - 2026)

Updated

Milestone Pharmaceuticals (MIST) reported Change in Account Payables of -$1.57 million for Q2 2026, compared with $544,000 a year earlier.

Analysis

Milestone Pharmaceuticals (MIST) Change in Account Payables (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Milestone Pharmaceuticals' Change in Account Payables came in at $3.81 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 18.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Milestone Pharmaceuticals 97.49 Mn -73.11 Mn - -1.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.57 Mn
Mar 31, 2026 4.38 Mn
Jun 30, 2025 544,000.00
Mar 31, 2025 452,000.00
API Access

Milestone Pharmaceuticals Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=MIST&period=max&api_key=YOUR_API_KEY